Department of Clinical Development
ACT Biotech Inc
United States of America
Dr. Patel has been working in the industry as an experienced clinical scientist who brings expertise in the areas of oncology drug development and the clinical management of Phase I-III clinical trials. He has strong background in strategic clinical drug development to maximize product value through life cycle management, research and clinical development, education, training and key opinion leader development. Prior to joining ACT, he served as the head/Global Clinical Lead (GCL) of Onyx and Bayer led Nexavar® clinical development program and provided leadership role in the management of two large oncology programs.